Immunotherapy in lung cancer brain metastases
Abstract Brain metastases (BM) occur frequently in lung cancer, particularly in non-small cell lung cancer (NSCLC) patients and remain a significant cause of morbidity and mortality. Standard therapies have limited efficacy due to poor crossing of the blood-brain barrier and the distinct features be...
Saved in:
| Main Authors: | Eunice Paisana, Rita Cascão, Magda Alvoeiro, Francisco Félix, Guilherme Martins, Carla Guerreiro, Rafael Roque, Rafael Cruz, Teresa R. Pacheco, Ana Cristina Amado, Filipa Ferro, Andrea Lopes Machado, Ana Sofia Vilariça, Direndra Hasmucrai, Paula Alves, Claudia C. Faria |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00901-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pembrolizumab plus Pemetrexed and Platinum in Metastatic Non-Squamous Non-Small Cell Lung Cancer: A Real-Life Study at a Portuguese Centre
by: Maria João Santos, et al.
Published: (2025-02-01) -
Criteria for Responses of Renal Cancer Metastases to Targeted and Immunotherapy
by: V. S. Blinov, et al.
Published: (2020-09-01) -
Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics
by: Mu Li, et al.
Published: (2025-08-01) -
Unlocking the Role of Metabolic Pathways in Brain Metastatic Disease
by: Madalena Pinto, et al.
Published: (2025-05-01) -
Metabolic mechanisms of immunotherapy resistance
by: Luis Cabezón-Gutiérrez, et al.
Published: (2025-03-01)